A minimally invasive treatment option for patients
with knee osteoarthritis (OA).
Discover a non-surgical solution designed to target inflammation
and treat knee pain
What is GAE?
Geniculate Artery Embolization (GAE) reduces blood flow to inflamed tissues in the knee, alleviating pain associated with osteoarthritis.
• Minimally invasive
• Performed through a small catheter
• Targets hypervascular, inflamed synovial tissue
• Alleviates knee pain by reducing inflammation
How It Works?
A microcatheter is guided to the genicular arteries supplying the painful area. Embolic agents are injected in small amounts to block abnormal vessels while preserving normal blood flow.
BENEFITS OF GAE
• Significant pain relief often within 2–4 weeks
• Improvements lasting 1–2 years in many patients
• Minimally invasive; outpatient technique
• Helps patients who have failed conservative treatment
• High technical success rate: ~99.7%
• Pain reductions of 34–39 points on the VAS scale
IDEAL CANDIDATES
You may be a good candidate if you:
• Are 40–80 years old
• Have moderate–severe knee pain
• Have OA on X-ray without deformity/sclerosis
• Have persistent pain despite NSAIDs, PT, or injections
• Have localized knee tenderness
• You may NOT be a candidate if you have:
• Severe PAD (Peripheral Arterial Disease)
• Infection or malignancy
• Active knee infection
SAFETY & POSSIBLE SIDE EFFECTS
GAE is generally safe, with mostly mild and temporary effects.
Common temporary effects:
• Skin discoloration (10–65%)
• Puncture-site hematoma (10–17%)
• Mild erythema or fever
• Transient paresthesias
Rare complications:
• Bone infarction
• Postembolization syndrome (mild fever, nausea)
• Nerve irritation
Follow-up at 1 month is routine to assess progress and address concerns.
POST-TREATMENT CARE
To support healing and comfort:
• Avoid strenuous activity for 24 hours
• Stay well hydrated
• Use OTC pain medication if needed
• Rest for 2–3 days
• Keep the incision site clean
Outcomes
• ~70% of patients report long-lasting relief
• Improvements often begin within 2 weeks
• 78% achieve clinically significant pain reduction at 12 months
• Low rates of repeat treatment (8.3%) and knee replacement (5.2%)
We're here to support you
We appreciate your trust in TCVS and look forward to continuing to support your vascular health. If you have any questions.
Call us at 210-420-8621
Email us at info@tcavs.com